Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1028-1033.DOI: 10.12114/j.issn.1007-9572.2023.0422
Special Issue: 儿科最新文章合辑
• Frontiers of Medicine • Previous Articles Next Articles
Received:
2023-07-17
Revised:
2023-09-13
Published:
2024-03-20
Online:
2023-12-19
Contact:
LIN Zheng
通讯作者:
林征
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0422
评估工具 | 时间(年) | 测评形式 | 适用人群 | Cronbach's α系数 | 汉化版 | 优点 | 缺点 |
---|---|---|---|---|---|---|---|
青少年饮食紊乱调查问卷(EDY-Q)[ | 2013 | 自陈量表 | ≥14岁 | 0.62 | 无 | ①简单快捷 ②可以区分其他进食障碍 | ①信度较低 |
九项回避性/限制性摄食障碍筛查量表(NIAS)[ | 2017 | 自陈量表 | ≥12岁 | 多样本检验为0.79~0.90 | 有 | ①简单快捷 ②信效度较好 | ①需结合其他量表进行区分 ②不适合胃肠道疾病患者筛查 |
回避性/限制性摄食障碍父母报告版问卷(ARFID-Q-PR)[ | 2022 | 他评量表 | 2~10岁儿童 | 0.84 | 无 | ①可以区分其他进食障碍 ②信效度较好 | ①有待在多样本人群推广验证 |
异食癖、回避性/限制性摄食障碍和反刍障碍访谈(PARDI)[ | 2019 | 半结构化访谈 | 全年龄段使用 | 评估ARFID分量表各维度为0.83~0.93 | 无 | ①可用于诊断 ②信效度较好 | ①需要心理医生指导使用 ②大规模筛查人力成本较高 |
Table 1 Characteristics of ARFID assessment tools
评估工具 | 时间(年) | 测评形式 | 适用人群 | Cronbach's α系数 | 汉化版 | 优点 | 缺点 |
---|---|---|---|---|---|---|---|
青少年饮食紊乱调查问卷(EDY-Q)[ | 2013 | 自陈量表 | ≥14岁 | 0.62 | 无 | ①简单快捷 ②可以区分其他进食障碍 | ①信度较低 |
九项回避性/限制性摄食障碍筛查量表(NIAS)[ | 2017 | 自陈量表 | ≥12岁 | 多样本检验为0.79~0.90 | 有 | ①简单快捷 ②信效度较好 | ①需结合其他量表进行区分 ②不适合胃肠道疾病患者筛查 |
回避性/限制性摄食障碍父母报告版问卷(ARFID-Q-PR)[ | 2022 | 他评量表 | 2~10岁儿童 | 0.84 | 无 | ①可以区分其他进食障碍 ②信效度较好 | ①有待在多样本人群推广验证 |
异食癖、回避性/限制性摄食障碍和反刍障碍访谈(PARDI)[ | 2019 | 半结构化访谈 | 全年龄段使用 | 评估ARFID分量表各维度为0.83~0.93 | 无 | ①可用于诊断 ②信效度较好 | ①需要心理医生指导使用 ②大规模筛查人力成本较高 |
[1] |
|
[2] |
|
[3] |
WHO. ICD-11死因和疾病统计(MMS)[EB/OL]. (2023-01)[2023-05-20].
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
American Psychiatric Association. Diagnostic and statistical manual of mental disorders,fifth edition,text revision(DSM-5-TR)[EB/OL]. [2023-05-20].
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
|
[54] |
|
[55] |
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[4] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[5] | CHU Yijing, YAN Yuge, GU Jie, XI Biao, ZHU Shanzhu, HUANG Jiaoling. Analysis of Factors Influencing the Retention Intention of Primary Healthcare Workers in China: a Comparison Based on Urban-rural Differences [J]. Chinese General Practice, 2025, 28(25): 3161-3168. |
[6] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[7] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[8] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[9] | HE Jinyu, ZHULIDUZI Jiesisibieke, ZHANG Ning, LIU Min, LIANG Wannian. Research on Blood Pressure Control and Its Determinants Among Hypertensive Patients Under Standardized Management in China: Status, Challenges, and Future Directions [J]. Chinese General Practice, 2025, 28(24): 2968-2971. |
[10] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[11] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[12] | XU Yutong, SU Wei, TANG Song, MA Shuang. A Comparative Study on Chinese Residents' Attitudes and Behaviors towards Traditional Chinese Medicine: an Empirical Analysis Based on the Data from the Chinese General Social Survey in 2011 and 2021 [J]. Chinese General Practice, 2025, 28(23): 2915-2923. |
[13] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[14] | DU Qiongliang, LIN Bailang, GUO Honghua. Research Progress and Implications of Group Well-child Care [J]. Chinese General Practice, 2025, 28(21): 2672-2678. |
[15] | HU Wanqin, YU Shenyan, CAO Xuehua, XIANG Feng, JIA Yu. Factors Associated with Precocious Puberty in Chinese Children: a Meta-analysis [J]. Chinese General Practice, 2025, 28(21): 2661-2671. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||